Back to results
US 2019/0274645 A1Published application
Cancer binding radio-opaque peptides that are targeted for disintegration by radiant energy
AssigneeCAO Group, Inc.
InventorSteven D. Jensen
Life of this patent
Estimating the term…
Abstract
A compound may comprise a radio-opaque moiety that is readily identifiable by radiography, such as X-rays and the like. The compound may be configured to bind to cancerous cells and minimizes collection within healthy tissue. The compound may readily absorb a wavelength of light that is matched to a radiant energy source that emits light at or near said wavelength.
Claims1
A compound comprising:
- a radio-opaque moiety;
- wherein the compound is configured to bind to cancerous cells and minimizes collection within healthy tissue;
- and
- wherein the compound readily absorbs a wavelength of light that is matched to a radiant energy source that emits light at or near said wavelength.
1 more element
Dependencies are inferred from the claim text.